查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1553511

治療藥物監測市場規模、佔有率和趨勢分析報告：按產品、藥物類別、最終用途、地區和細分市場預測，2024-2030

Therapeutic Drug Monitoring Market Size, Share & Trends Analysis Report By Product (Equipment, Consumables), By Drug Class (Antiarrhythmic Drugs), By End Use (Diagnostic Centers), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

治療藥物監測市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計2030年全球治療藥物監測市場規模將達23.2億美元，2024年至2030年複合年成長率為3.8%。

即時護理 (PoC) 設備的最新技術進步有可能徹底改變個人化、預測性和預防性醫療保健。治療藥物監測（TDM）是製定患者客製化治療計劃的基本組成部分，而能夠定量測量藥物濃度的PoC診斷設備的出現是醫療保健領域精準化的重要一步，在支持方面發揮著極其重要的作用。領域的發展。然而，PoC設備在病患監測中的廣泛應用仍然滯後。這種開拓的機會的存在是市場成長的重要驅動力之一。

在器官移植後給藥方案的早期階段採用連續治療藥物和代謝物監測是重症患者醫學和器官移植領域的主要應用，預計將在預測期內推動治療藥物監測市場。此外，癲癇和癌症等疾病負擔的增加、政府舉措的增加以及未滿足的需求較高是預計將進一步推動該市場出現的一些關鍵決定因素。

治療藥物監測市場報告亮點

  • 2023年，消耗品領域佔市場佔有率超過65.4%。這是實驗室對耗材的大量需求以及套件和試劑的重複購買的結果。
  • 預計免疫抑制劑領域成長最快，在預測期內年複合成長率為 5.3%。
  • 2023年的市場佔有率由醫院領域主導。大型醫院採用各種基本技術來進行免疫測量。這些包括化學冷光、比濁法、比色法和螢光，可用於測試多種藥物。
  • 隨著新的 TDM就地檢驗設備的引入，免疫抑制劑的治療藥物監測成為成長最快的應用之一，以評估所施用的免疫抑制劑及其代謝物的濃度。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章治療藥物監測市場變數、趨勢和範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 治療藥物監測市場分析工具
    • 波特的分析
    • PESTEL分析

第4章 治療藥物監測市場：依產品估計和趨勢分析

  • 細分儀表板
  • 治療藥物監測市場：2024 年和 2030 年按產品分類的變異分析
  • 裝置
  • 消耗品

第5章治療藥物監測市場：依藥物類別估計與趨勢分析

  • 細分儀表板
  • 治療藥物監測市場：2024 年和 2030 年藥物類別變化分析
  • 抗心律不整藥物
  • 免疫抑制劑
  • 抗癲癇藥
  • 其他

第6章 治療藥物監測市場：依最終用途分類的估計與趨勢分析

  • 細分儀表板
  • 治療藥物監測市場：2024 年和 2030 年最終用途的變化分析
  • 醫院
  • 診斷中心
  • 其他

第7章 治療藥物監測市場：區域估計與趨勢分析

  • 2024 年及 2030 年治療藥物監測市場佔有率（按地區）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Abbott
    • ALPCO
    • Beckman Coulter, Inc
    • Bio-Rad Laboratories, Inc.
    • Thermo Fisher Scientific Inc.
    • Chromsystems Instruments &Chemicals GmbH
    • F.Hoffmann-La Roche Ltd.
    • Randox laboratories Ltd
    • Siemens Healthineers AG.
    • biomerieux, Inc.
簡介目錄
Product Code: GVR-1-68038-032-3

Therapeutic Drug Monitoring Market Growth & Trends:

The global therapeutic drug monitoring market size is estimated to reach USD 2.32 billion by 2030, expanding at a CAGR of 3.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. Recent technological advancements in the Point-of-Care (PoC) devices hold considerable transformative promises for the personalized predictive and preventive medicine. Therapeutic Drug Monitoring (TDM) forms a foundational part to the devising of personalized treatment plans for patients; and the advent of PoC diagnostic devices that yield quantitative measurements of the drug concentration plays a pivotal role in supporting the development of the precision medicine field in the healthcare sector. However, the broad application of the PoC devices for patient monitoring is still lagging behind. The presence of this untapped opportunity is one of the high impact rendering drivers for the market growth.

The employment of continuous therapeutic drug and metabolite monitoring in the early phase of the medication regimen, administered post-organ transplantation, forms a major application in the areas of critical care medicine and organ transplantation, which is expected to propel the growth of the therapeutic drug monitoring market over the forecast period. In addition, the imposing burden of diseases, such as epilepsy and cancer, the rising government initiatives, and the presence of high-unmet needs are some of the crucial determinants expected to further favor the emergence of this market.

Therapeutic Drug Monitoring Market Report Highlights:

  • The consumables segment covered over 65.4% of the market share in 2023 as a consequence of the extensive requirement of the consumables in the research laboratories and due to the repeat purchase of the kits and reagents.
  • The immunosuppressants segment is expected to grow fastest, with a compounded annual growth rate of 5.3% over the forecast period.
  • The hospital segment dominated the market share in 2023. In larger hospitals, various underlying technologies are employed to perform immunoassays; these comprise chemiluminescence, nephelometry, colorimetry, and fluorescence, which are available for the testing of a wide ranging drug panel.
  • The drug monitoring for the immunosuppressants is one of the fastest growing application segments owing to the introduction of novel TDM point-of-care testing devices for the evaluation of the concentration of administered immunosuppressants and the complementary metabolites, in order to achieve a prominent therapeutic effect while preventing drug toxicity events in patients that have undergone transplantations.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Therapeutic Drug Monitoring Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Therapeutic Drug Monitoring Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Therapeutic Drug Monitoring Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Therapeutic Drug Monitoring Market: Product Movement Analysis, 2024 & 2030 (USD Million)
  • 4.3. Equipment
    • 4.3.1. Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Immunoassay Analyzers
      • 4.3.2.1. Immunoassay Analyzers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Clinical Chemistry Analyzers
      • 4.3.3.1. Clinical Chemistry Analyzers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Chromatography & MS detectors
      • 4.3.4.1. Chromatography & MS detectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Consumables
    • 4.4.1. Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Therapeutic Drug Monitoring Market: Drug Class Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Therapeutic Drug Monitoring Market: Drug Class Movement Analysis, 2024 & 2030 (USD Million)
  • 5.3. Antiarrhythmic Drugs
    • 5.3.1. Antiarrhythmic Drugs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Immunosuppressants
    • 5.4.1. Immunosuppressants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Antiepileptic Drugs
    • 5.5.1. Antiepileptic Drugs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Therapeutic Drug Monitoring Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Therapeutic Drug Monitoring Market: End Use Movement Analysis, 2024 & 2030 (USD Million)
  • 6.3. Hospitals
    • 6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Diagnostic Centers
    • 6.4.1. Diagnostics Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Therapeutic Drug Monitoring Market: Regional Estimates & Trend Analysis

  • 7.1. Therapeutic Drug Monitoring Market Share, By Region, 2024 & 2030 (USD Million)
  • 7.2. North America
    • 7.2.1. North America Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. France Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Italy Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Spain Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Norway Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Japan Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. China Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Australia Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. South Korea
      • 7.4.6.1. South Korea Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Thailand Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Saudi Arabia Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. UAE Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Therapeutic Drug Monitoring Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Abbott
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. ALPCO
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. Beckman Coulter, Inc
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. Bio-Rad Laboratories, Inc.
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. Thermo Fisher Scientific Inc.
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. Chromsystems Instruments & Chemicals GmbH
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. F.Hoffmann-La Roche Ltd.
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. Randox laboratories Ltd
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. Siemens Healthineers AG.
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives
    • 8.4.10. biomerieux, Inc.
      • 8.4.10.1. Participant's Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Recent Developments/ Strategic Initiatives